企業概要
OneMedNet Corporation is a healthcare software enterprise that specializes in delivering digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company operates within the Healthcare sector, specifically focusing on the Health Information Services industry, where it facilitates the critical flow of regulatory-grade imaging and clinical data for pharmaceutical and device manufacturing clients. As a publicly traded entity with the ticker symbol ONMD, the company currently maintains a market capitalization of $45.94M, reflecting its valuation in the public markets. Its annual revenue over the trailing twelve months stands at $1.36M, while the total employee count is listed as N/A in available filings. These financial figures indicate that OneMedNet operates as a micro-cap entity with a relatively modest revenue base, suggesting a small-scale operation that is still in a phase of significant expansion or restructuring rather than mature market dominance.
財務健全性
Over the trailing twelve months, the company generated $1.36M in revenue but recorded a net loss of $2,801,000, revealing a substantial gap between top-line sales and bottom-line profitability driven by high operational expenses. The EBITDA for the same period was -$9,602,000, further highlighting the company's inability to generate operating cash flow from its core business activities at this stage. Free cash flow stands at -$7,840,750, indicating that the company is burning cash and lacks the immediate financial flexibility to fund capital expenditures or acquisitions without external financing. The gross margin is reported at -37.0%, an unusual negative figure that suggests the cost of revenue significantly exceeds the direct sales price, potentially due to high infrastructure costs or specific contract structures. Operating margin stands at -345.9% and profit margin at -206.1%, both negative figures that underscore the intense pressure on the company to achieve operational leverage before becoming profitable. On the balance sheet, the company holds $585,000 in cash against $974,000 in debt, resulting in a debt-to-equity ratio that is N/A due to equity structure issues or negative book value. The current ratio is 0.43, a metric below 1.0 that indicates the company possesses less current assets than current liabilities, signaling potential short-term liquidity challenges in meeting obligations. Return on equity is N/A, while return on assets is -205.6%, revealing that management is currently destroying shareholder value relative to the asset base employed.
バリュエーション評価
The trailing P/E ratio is N/A because the company is unprofitable, and the forward P/E is also N/A, meaning traditional earnings-based valuation metrics cannot be applied to assess the company's future earnings trajectory. The price-to-book ratio is -15.44, a negative multiple that indicates the market is valuing the company significantly below its net book value, often seen in distressed or turnaround situations rather than growth scenarios. The price-to-sales ratio stands at 33.80, which is an extremely high multiple relative to its $1.36M in revenue, suggesting that the market is pricing in substantial future growth expectations or speculative premiums that are not supported by current earnings. The EV/EBITDA multiple is -4.83, another negative metric that reflects the company's negative earnings before interest, taxes, depreciation, and amortization and its reliance on external capital. The stock has traded between a 52-week low of $0.30 and a 52-week high of $4.22, providing a range within which the current price oscillates based on market sentiment. The beta value is 1.17, indicating that the stock's price volatility is higher than the broader market, as it moves approximately 17% more than the market index in either direction.
Growth & Income
Revenue growth year-over-year is reported at an extraordinary 3326.9%, while earnings growth is N/A due to the company's continued unprofitability. The massive revenue growth rate suggests rapid market penetration or consolidation of revenue streams, whereas the absence of earnings growth highlights that this top-line expansion has not yet translated into net income. Since the company does not pay a dividend, the dividend yield is N/A and the payout ratio is 0.0%, meaning the firm retains all earnings for reinvestment rather than distributing income to shareholders. This 0.0% payout ratio is sustainable given the company's lack of dividends, as the primary strategy is to utilize available cash for business expansion despite the current net loss. The overall growth and income profile depicts a high-volatility micro-cap technology company that prioritizes aggressive revenue expansion and market share acquisition over immediate profitability or income generation for investors.